- Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model(2022)
Auteurs: Thomas Ertveldt, L De Beck, Kirsten De Ridder, Hanne Locy, Wout de Mey, Cleo Goyvaerts, Quentin Lecocq, Hannelore Ceuppens, Yannick De Vlaeminck, Robin Maximilian Awad, et al.
Pagina's: 1136-1148
- Computer-aided detection and segmentation of malignant melanoma lesions on whole-body 18F-FDG PET/CT using an interpretable deep learning approach(2022)
Auteurs: Ine Dirks, Marleen Keyaerts, Bart Neyns, Jef Vandemeulebroucke
- TNF-alpha-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy(2022)
Auteurs: Kirsten De Ridder, Hanne Locy, Elisa Piccioni, Miren Ibarra Zuazo, Robin Maximilian Awad, Stefaan Verhulst, Mathias Van Bulck, Yannick De Vlaeminck, Quentin Lecocq, Eva Reijmen, et al.
- The road to personalized myeloma medicine(2022)
Auteurs: Janik Puttemans, Benoit Stijlemans, Marleen Keyaerts, Sam Vander Meeren, Wim Renmans, Karel Fostier, Pieterjan Debie, Heleen Hanssens, Magdalena Rodak, Marek Pruszynski, et al.
Pagina's: 159-169
- Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer(2021)
Auteurs: Quentin Lecocq, Pieterjan Debie, Janik Puttemans, Robin Maximilian Awad, L De Beck, Thomas Ertveldt, Yannick De Vlaeminck, Cleo Goyvaerts, Geert Raes, Marleen Keyaerts, et al.
- Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade(2021)
Auteurs: Quentin Lecocq, Robin Maximilian Awad, Yannick De Vlaeminck, Wout de Mey, Thomas Ertveldt, Cleo Goyvaerts, Geert Raes, Kris Thielemans, Marleen Keyaerts, Nick Devoogdt, et al.
Pagina's: 1638-1644
- Undetectable thyroglobulin makes 123I whole-body scan and stimulated thyroglobulin obsolete in follow-up care of differentiated thyroid cancer(2021)
Auteurs: Bastiaan Sol, Bert Bravenboer, B Velkeniers, Steven Raeymaeckers, Marleen Keyaerts, Corina Emilia Andreescu
- Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade(2021)
Auteurs: Robin Maximilian Awad, Quentin Lecocq, Katty Zeven, Thomas Ertveldt, L De Beck, Hannelore Ceuppens, Katrijn Broos, Yannick De Vlaeminck, Cleo Goyvaerts, Magali Verdonck, et al.
Pagina's: 172-182
- Lyophilization of NOTA-sdAbs(2021)
Auteurs: Henri Vincent Baudhuin, Pieter-Jan Van Bockstal, Thomas De Beer, Ilse Vaneycken, Jessica Bridoux, Geert Raes, Vicky Caveliers, Marleen Keyaerts, Nick Devoogdt, Tony Lahoutte, et al.
Pagina's: 194-204
- Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients(2021)
Auteurs: Matthias D'Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, Francois P Duhoux, Christel Fontaine, Marian Vanhoeij, Albert D Windhorst, Frank Van Der Aa, et al.
Pagina's: 1097-1105